Lupin 2024

Sanofi’s Xyzal Allergy 24HR hits store shelves

Print Friendly, PDF & Email

BRIDGEWATER, N.J. —  Sanofi Consumer Healthcare has rolled out Xyzal Allergy 24HR, an over-the-counter oral antihistamine, to retail stores nationwide.

Sanofi said Tuesday that Xyzal, which had been available by prescription only for nearly a decade, is now available OTC in two formulations: 5-mg tablets for ages 6 years and older, and a 0.5 mg/ml oral solution for ages 2 years and older. The company announced Food and Drug Administration approval for the OTC product in February.

Xyzal Allergy 24HR box_SanofiXyzal Allergy 24HR provides continuous, maximum-strength relief of such symptoms as sneezing; runny nose; itchy, watery eyes; and itchy nose or throat in a single daily dose.

Sanofi noted that the product offers all night and all day allergy relief that can help patients get a better night’s sleep and a better day’s productivity.

To that end, the company on Tuesday released results of a “social experiment” in which 160 participants — 80 allergy sufferers and 80 non-sufferers — wore a wearable device for 30 days to track their sleep and activity. The allergy sufferer participants also completed a daily survey to track perceptions of their symptoms, sleep patterns and activities to provide further context for the wearable device data.

Among the findings were that allergy sufferers had a harder time falling asleep and staying asleep than people without allergies, Sanofi said. Allergy symptoms were the top factor that negatively impacted the sleep of these allergy sufferers, even more than stress, discomfort, temperature or work. The experiment found that an allergy sufferer’s sleep could be disrupted nearly four times more than that of a person without allergies.

Allergy sufferers were less rested and less physically active during the day than people without allergies. For example, allergy sufferers traveled an average of only 3.16 miles a day while active, whereas people without allergies traveled 3.35 miles.

Sanofi said that Xyzal is partnering with renowned allergist Dr. Neeta Ogden to encourage allergy sufferers to “wise up” about the importance of managing their allergies this spring so they can have a better night’s sleep and “rise up” in the morning to go about their day.

“Many allergy sufferers have gotten so used to their symptoms that they don’t even realize how significantly they may be impacting their day-to-day lives, including everything from their sleep at night to their productivity during the day. But the results of this social experiment should serve as a wake-up call,” Ogden commented. “If your allergy symptoms aren’t under control, it’s time to educate yourself about both your triggers and your treatment options so you can find relief that doesn’t rest and enjoy the spring season.”

Prescription-to-OTC medications are increasingly being selected by consumers — especially allergy sufferers — to alleviate their symptoms. New research from Consumer Healthcare Products Association and Nielsen released earlier this month found that 60% adult allergy sufferers use only OTCs for treatment, up from just more than half in 2009.


ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21